[HTML][HTML] The Advisory Committee on Immunization Practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5–11 years …
KR Woodworth - MMWR. Morbidity and Mortality Weekly Report, 2021 - cdc.gov
KR Woodworth
MMWR. Morbidity and Mortality Weekly Report, 2021•cdc.govOn November 2, 2021, after a systematic review of available data, the Advisory Committee
on Immunization Practices made an interim recommendation for use of the Pfizer-BioNTech
COVID-19 vaccine in children aged 5–11 years in the United States for prevention of COVID-
19.
on Immunization Practices made an interim recommendation for use of the Pfizer-BioNTech
COVID-19 vaccine in children aged 5–11 years in the United States for prevention of COVID-
19.
On November 2, 2021, after a systematic review of available data, the Advisory Committee on Immunization Practices made an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in children aged 5–11 years in the United States for prevention of COVID-19.
cdc.gov